Xtx Topco LTD Abb Vie Inc. Transaction History

Xtx Topco LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $1.14 Million - $1.32 Million	8,513 New	8,513 $1.27 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $380,629 - $456,474	2,752 New	2,752 $445,000
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $1.29 Million - $1.64 Million	-9,352 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $1.23 Million - $1.53 Million	9,352 New	9,352 $1.52 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $306,927 - $388,352	-2,857 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $303,984 - $345,068	2,857 New	2,857 $308,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.